$2.18
1.36% yesterday
Nasdaq, Aug 12, 07:31 pm CET
ISIN
US7443752057
Symbol
PMDI

Psychemedics Corporation Stock price

$2.18
-0.12 5.22% 1M
+0.08 3.81% 6M
-0.06 2.68% YTD
+0.35 19.13% 1Y
-4.47 67.22% 3Y
-2.89 57.00% 5Y
-9.54 81.40% 10Y
-11.58 84.15% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
-0.03 1.36%

Key metrics

Basic
Market capitalization
$13.5m
Enterprise Value
$12.4m
Net debt
positive
Cash
$1.4m
Shares outstanding
6.1m
Valuation (TTM | estimate)
P/E
negative | -
P/S
0.7 | -
EV/Sales
0.6 | -
EV/FCF
14.7
P/B
2.6
Dividends
DPS
$0.14
Yield 1Y | 5Y
6.3% | 3.7%
Growth 1Y | 5Y
-33.3% | -27.3%
Payout 1Y | 3Y
-19.4% | -38.8%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$19.7m | -
EBITDA
$-700.0k | -
EBIT
$-1.9m | -
Net Income
$-1.9m | -
Free Cash Flow
$840.0k
Growth (TTM | estimate)
Revenue
-10.9% | -
EBITDA
41.7% | -
EBIT
35.3% | -
Net Income
55.3% | -
Free Cash Flow
151.2%
Margin (TTM | estimate)
Gross
36.1%
EBITDA
-3.6% | -
EBIT
-9.6%
Net
-9.5% | -
Free Cash Flow
4.3%
Financial Health
Equity Ratio
61.7%
Return on Equity
-36.3%
ROCE
-33.7%
ROIC
-
Debt/Equity
0.1
More
EPS
$-0.3
FCF per Share
$0.1
Short interest
0.3%
Employees
-
Rev per Employee
-
Show more

Is Psychemedics Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Financial data from Psychemedics Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
20 20
11% 11%
100%
- Direct Costs 13 13
8% 8%
64%
7.10 7.10
16% 16%
36%
- Selling and Administrative Expenses 8.25 8.25
19% 19%
42%
- Research and Development Expense 0.75 0.75
35% 35%
4%
-0.70 -0.70
42% 42%
-4%
- Depreciation and Amortization 1.19 1.19
31% 31%
6%
EBIT (Operating Income) EBIT -1.89 -1.89
35% 35%
-10%
Net Profit -1.86 -1.86
55% 55%
-9%

In millions USD.

Don't miss a Thing! We will send you all news about Psychemedics Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.

Head office United States
CEO Brian Hullinger
Founded 1986
Website www.psychemedics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today